Related Experiment Video

Updated: Jun 22, 2026

Real-time Digital Imaging of Leukocyte-endothelial Interaction in Ischemia-reperfusion Injury (IRI) of the Rat Cremaster Muscle
15:07

Real-time Digital Imaging of Leukocyte-endothelial Interaction in Ischemia-reperfusion Injury (IRI) of the Rat Cremaster Muscle

Published on: August 5, 2012

[C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication]

Jeppe Zacho1, Anne Tybjaerg-Hansen, Jan Skov Jensen

  • 1Herlev Hospital, Klinisk Biokemisk Afdeling.

Ugeskrift for Laeger
|June 5, 2009
PubMed

Insights

Elevated C-reactive protein (CRP) levels correlate with higher ischemic vascular disease risk. However, genetic variations influencing CRP did not confirm a causal link to increased disease risk in this study.

Area of Science:

  • Biochemistry
  • Genetics
  • Epidemiology

Context:

  • C-reactive protein (CRP) is a biomarker for inflammation.
  • Elevated CRP levels are linked to increased risk of ischemic vascular diseases.
  • The causal relationship between CRP levels and ischemic vascular disease requires further investigation.

Purpose:

  • To investigate the causal association between C-reactive protein (CRP) levels and the risk of ischemic vascular disease.
  • To determine if genetic variations that increase CRP levels translate to a higher risk of ischemic heart and cerebrovascular diseases.

Summary:

  • Observational data showed higher CRP levels (> 3 vs < 1 mg/l) associated with increased ischemic heart (1.6x) and cerebrovascular disease (1.3x) risk.
  • Four CRP polymorphisms significantly increased CRP levels by 64%, theoretically predicting a 32% and 25% increased risk for ischemic heart and cerebrovascular diseases, respectively.
  • Despite the predicted risk, the specific genotype combinations were not statistically associated with an increased risk of ischemic vascular disease, challenging a direct causal link.

Impact:

  • Suggests that the observed association between elevated CRP and ischemic vascular disease may not be directly causal.
  • Highlights the complexity of inflammatory markers and cardiovascular risk.
  • Warrants further research into the mechanisms underlying the association between CRP and vascular health.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...